Topical carbonic anhydrase II inhibitor that reduces aqueous humor production in the ciliary body, lowering IOP. Unlike systemic CAIs (acetazolamide), topical brinzolamide has minimal systemic side effects.
At a glance
Class
Ophthalmic Carbonic Anhydrase Inhibitor
Storage
Store at room temperature; shake well before use
Dosing
Used for chronic glaucoma management — reduces IOP ~15–20%
Safety
IOP measurementOcular surface tolerance
Interactions
No documented interactions.
FAQs
Frequently asked questions
›What is Brinzolamide Ophthalmic?
Brinzolamide Ophthalmic is a ophthalmic carbonic anhydrase inhibitor used in pets. Topical carbonic anhydrase II inhibitor that reduces aqueous humor production in the ciliary body, lowering IOP. Unlike systemic CAIs (acetazolamide), topical brinzolamide has minimal systemic side effects.
›What is Brinzolamide Ophthalmic used for in pets?
Brinzolamide Ophthalmic is used in veterinary medicine for: Used for chronic glaucoma management — reduces IOP ~15–20%; Used for feline glaucoma.
›What is the Brinzolamide Ophthalmic dose for dogs?
For dogs, Brinzolamide Ophthalmic is typically dosed as follows — Used for chronic glaucoma management — reduces IOP ~15–20%: undefined undefined Ophthalmic q8–12h. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›What is the Brinzolamide Ophthalmic dose for cats?
For cats, Brinzolamide Ophthalmic is typically dosed as follows — Used for feline glaucoma: undefined undefined Ophthalmic q8–12h. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›Does Brinzolamide Ophthalmic need a prescription?
Yes. Brinzolamide Ophthalmic is a prescription medication and should only be administered under veterinary supervision.
References
References
Textbooks & handbooks
- Plumb, D.C. Plumb's Veterinary Drug Handbook. 10th ed., Wiley-Blackwell, 2023.
- Vail, D.M., Thamm, D.H., & Liptak, J.M. (eds.). Withrow & MacEwen's Small Animal Clinical Oncology. 6th ed., Saunders/Elsevier, 2020.
- Riviere, J.E., & Papich, M.G. (eds.). Veterinary Pharmacology and Therapeutics. 10th ed., Wiley-Blackwell, 2018.
- National Research Council. Nutrient Requirements of Dogs and Cats. National Academies Press, Washington DC, 2006.
- The Merck Veterinary Manual. Merck & Co., Online edition. https://www.merckvetmanual.com/
Clinical guidelines & consensus
- Fletcher, D.J., Boller, M., Brainard, B.M., et al. "RECOVER Evidence and Knowledge Gap Analysis on Veterinary CPR." Journal of Veterinary Emergency and Critical Care, 2012;22(S1):S102–S131.
- American Animal Hospital Association. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. AAHA Press.
Journals & peer-reviewed studies
- Hogan, D.F., Fox, P.R., Jacob, K., et al. "Secondary prevention of cardiogenic arterial thromboembolism in the cat: The FAT CAT study." Journal of Veterinary Cardiology, 2015;17(Suppl 1):S306–S317.
- Boswood, A., Häggström, J., Gordon, S.G., et al. "Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial." Journal of Veterinary Internal Medicine, 2016;30(6):1765–1779.
- ASPCA Animal Poison Control Center. Toxicology and Poison Management Guidelines. American Society for the Prevention of Cruelty to Animals. https://www.aspca.org/pet-care/animal-poison-control
Regulatory & approvals
- Central Drugs Standard Control Organisation (CDSCO), Government of India. Veterinary Drug Approval Registry, 1969–2026. Directorate General of Health Services. https://cdsco.gov.in/
Databases
- Washington State University, College of Veterinary Medicine. Veterinary Clinical Pharmacology Laboratory (VCPL) — MDR1 Multidrug Sensitivity Database. https://vcpl.vetmed.wsu.edu/
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet.
Find a vet near you →